Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Human Pathology
|
May 1, 1994
Expression of the p53 gene in Hodgkin's disease: dissociation between immunohistochemistry and clinicopathological data
L Xerri, R Bouabdallah, J Camerlo, et al.
Pacing and Clinical Electrophysiology : PACE
|
February 1, 1992
A new pacemaker algorithm for continuous capture verification and automatic threshold determination: elimination of pacemaker afterpotential utilizing a triphasic charge balancing system
G K Feld, C J Love, J Camerlo, et al.
The Journal of Pathology
|
February 1, 1995
PCR-mismatch analysis of p53 gene mutation in Hodgkin's disease
L Xerri, P Parc, R Bouabdallah, et al.
Leukemia & Lymphoma
|
May 30, 2001
Simultaneous occurrence of kaposi's sarcoma and chronic myelogenous leukemia
N Vey, J Camerlo, L Xerri, et al.
Hematology and Cell Therapy
|
May 27, 1999
The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell technology
C Chabannon, G Novakovitch, J L Blache, et al.
Anti-Cancer Drugs
|
June 23, 1999
Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinoma
G Gravis, F Pech-Gourgh, P Viens, et al.
British Journal of Haematology
|
April 1, 1996
Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: absence of eradication of the PNH clone and dependence of response on cyclosporin A administration
A M Stoppa, N Vey, D Sainty, et al.
Leukemia & Lymphoma
|
June 1, 1995
Persistence of BCR/ABL mRNA-expressing bone-marrow cells in patients with chronic myelogenous leukemia in complete cytogenetic remission induced by interferon-alpha therapy
F Eberlé, Y Toiron, J Camerlo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 21, 2002
Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles
D Genre, C Protière, G Macquart-Moulin, et al.
Revue Francaise De Transfusion Et Immuno-Hematologie
|
November 1, 1985
Repeated high-dose-melphalan with autologous bone marrow transplantation in acute non lymphocytic leukemia
B Mascret, D Maraninchi, J A Gastaut, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Human Pathology
|
May 1, 1994
Expression of the p53 gene in Hodgkin's disease: dissociation between immunohistochemistry and clinicopathological data
L Xerri, R Bouabdallah, J Camerlo, et al.
Pacing and Clinical Electrophysiology : PACE
|
February 1, 1992
A new pacemaker algorithm for continuous capture verification and automatic threshold determination: elimination of pacemaker afterpotential utilizing a triphasic charge balancing system
G K Feld, C J Love, J Camerlo, et al.
The Journal of Pathology
|
February 1, 1995
PCR-mismatch analysis of p53 gene mutation in Hodgkin's disease
L Xerri, P Parc, R Bouabdallah, et al.
Leukemia & Lymphoma
|
May 30, 2001
Simultaneous occurrence of kaposi's sarcoma and chronic myelogenous leukemia
N Vey, J Camerlo, L Xerri, et al.
Hematology and Cell Therapy
|
May 27, 1999
The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell technology
C Chabannon, G Novakovitch, J L Blache, et al.
Anti-Cancer Drugs
|
June 23, 1999
Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinoma
G Gravis, F Pech-Gourgh, P Viens, et al.
British Journal of Haematology
|
April 1, 1996
Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: absence of eradication of the PNH clone and dependence of response on cyclosporin A administration
A M Stoppa, N Vey, D Sainty, et al.
Leukemia & Lymphoma
|
June 1, 1995
Persistence of BCR/ABL mRNA-expressing bone-marrow cells in patients with chronic myelogenous leukemia in complete cytogenetic remission induced by interferon-alpha therapy
F Eberlé, Y Toiron, J Camerlo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 21, 2002
Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles
D Genre, C Protière, G Macquart-Moulin, et al.
Revue Francaise De Transfusion Et Immuno-Hematologie
|
November 1, 1985
Repeated high-dose-melphalan with autologous bone marrow transplantation in acute non lymphocytic leukemia
B Mascret, D Maraninchi, J A Gastaut, et al.
Page
of 5